Douglas A Pepper's Net Worth

$610 Million

Estimate Recalculated Feb 21, 2024 06:00PM EST

Who is Douglas A Pepper?

Douglas A Pepper has an estimated net worth of $610 Million. This is based on reported shares across multiple companies, which include TESARO, Inc., EnteroMedics Inc, Invuity, Inc., Trius Therapeutics Inc, GLAUKOS Corp, Braze, Inc., Carbylan Therapeutics, Inc., Marketo, Inc., and Transcept Pharmaceuticals Inc.

SEC CIK

Douglas A Pepper's CIK is 0001381839

Past Insider Trading and Trends

2022 was Douglas A Pepper's most active year for acquiring shares with 38 total transactions. Douglas A Pepper's most active month to acquire stocks was the month of August. 2021 was Douglas A Pepper's most active year for disposing of shares, totalling 24 transactions. Douglas A Pepper's most active month to dispose stocks was the month of October. 2021 saw Douglas A Pepper paying a total of $21,125,000.00 for 27,243,155 shares, this is the most they've acquired in one year. In 2013 Douglas A Pepper cashed out on 12,430,626 shares for a total of $70,818,664.12, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

EnteroMedics Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+724.94%
1.36M
1.55M
Nov 20
Form 4
187.5K
$8.00
$1,500,000.00
187.5K
Nov 15
Form 3
0
0
No matching records found

Invuity, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
1.08M
1.08M
Jun 18
Form 4
1.08M
1.08M
Jun 18
Form 3
0
0
No matching records found

Trius Therapeutics Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
3.55M
$4.77
3.55M
Aug 6
Form 3
0
0
No matching records found

GLAUKOS Corp (GKOS) Snapshot price: $94.37

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.6M
2.6M
Jun 30
Form 3
0
0
No matching records found

Carbylan Therapeutics, Inc. (KALV) Snapshot price: $14.53

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
4.62M
$5.00
4.62M
Apr 14
Form 3
0
0
No matching records found